Life Technologies Corporation Selects XIFIN Revenue Cycle Management Platform for Molecular Diagnostics

  Life Technologies Corporation Selects XIFIN Revenue Cycle Management
  Platform for Molecular Diagnostics

    Industry Leader Processes More Than 60 Percent of Molecular Claims by
              Laboratories Specializing in Molecular Diagnostics

Business Wire

SAN DIEGO -- November 12, 2012

XIFIN Inc., the financial cloud computing company revolutionizing the business
of healthcare diagnostics from patient to payment, announced today that Life
Technologies Corporation, a global biotechnology company, has selected XIFIN’s
revenue cycle management technology platform for its newly launched
CLIA-certified laboratory services business.

In addition to providing Life Technologies with its next generation,
cloud-based RCM platform, XIFIN’s consulting division will be serving in the
capacity of strategic advisor on reimbursement initiatives with the objective
of demonstrating the value that real time, actionable, accessible and accurate
information plays in enhancing the role of diagnostics in the healthcare
continuum.

“The diagnostic services landscape is changing, with new players emerging from
the list of Fortune 500 companies,” stated Lâle White, CEO of XIFIN. “We are
proud of our leadership position in reimbursement and excited that
technology-savvy companies like Life Technologies recognize the critical role
our platform plays in the future of diagnostic business operations. Being
selected is a strong endorsement of both our technology and reimbursement
leadership, and the outstanding results we have delivered for our clients. We
look forward to a partnership that will advance the practice of health
diagnostics.”

“We selected XIFIN because we believe they offer the most effective and
comprehensive solution for our market, as well as a shared vision of real time
decision support and an end-to-end solution for the molecular pathologist,”
said Dr. Paul Billings, Chief Medical Officer of Life Technologies.

XIFIN processes more than 100 million claims per year across a wide variety of
healthcare segments including clinical, hospital outreach, anatomic pathology,
molecular diagnostics, toxicology, radiology and more. Customers see
significant improvements in profitability by collecting 8 percent additional
cash on average in the first 12 months, and have realized cumulative gains of
$1 billion in net cash collection, adjusted for growth.

About XIFIN

XIFIN delivers cloud-based revenue cycle management solutions that enable
diagnostic service providers to improve cash collections and gain efficiencies
that substantially improve the bottom line. XIFIN leverages its expertise and
collective intelligence to deliver automation, visibility, and control through
a partnership formula that ensures aligned goals, long-term focus on success,
and constant attention to ongoing improvement. The company has received
continual industry recognition, including being named to the Inc. 5000 fastest
growing privately-held companies for the past six years, and ranking among
Deloitte’s Technology Fast 500. To learn how XIFIN uniquely delivers revenue
cycle management, visit www.XIFIN.com, or follow XIFIN on Twitter at
www.twitter.com/#!/xifin.

Contact:

XIFIN, Inc.
Bill Taylor, 858-436-2995
Chief Marketing Officer
btaylor@xifin.com
or
Myla Wagner Public Relations
Myla Wagner, 925-736-7515
myla@mylawagnerpr.com
 
Press spacebar to pause and continue. Press esc to stop.